Detailed Information
Cited 11 time in 
Cited 10 time in 
Cited 10 time in
Metadata Downloads
Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon beta-1bopen accessFive severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b
- Other Titles
- Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b
- Authors
- Hong, Sun In; Ryu, Byung-Han; Chong, Yong Pil; Lee, Seungjun; Kim, Sunjoo; Kim, Ho Cheol; Hong, Kyung-Wook; Bae, In-Gyu; Cho, Oh-Hyun
- Issue Date
- Aug-2020
- Publisher
- Elsevier BV
- Keywords
- Coronavirus; COVID-19; Hydroxychloroquine; Interferon; Lopinavir/ritonavir; SARS-CoV-2
- Citation
- International Journal of Antimicrobial Agents, v.56, no.2
- Indexed
- SCIE
SCOPUS
- Journal Title
- International Journal of Antimicrobial Agents
- Volume
- 56
- Number
- 2
- ISSN
- 0924-8579
1872-7913
- Abstract
- [No abstract available]
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.